Lapatinib Active Not Recruiting Phase 2 Trials for Neoplasms, Breast Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02213042Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer
NCT00444535Lapatinib and Bevacizumab for Metastatic Breast Cancer